A2 Biotherapeutics
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$80M
A2 Biotherapeutics, Inc. develops novel cell therapies using its Tmod™ platform to selectively target tumor cells while sparing normal cells in cancer treatment.
Focus Areas
Biotech
cell therapy
cancer treatment
Tmod™ platform
clinical development
preclinical programs
Investors
